<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-134992</identifier>
<setSpec>0214-2597</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Community acquired pneumonias in the University Hospital of Salamanca</dc:title>
<dc:description xml:lang="en">Introduction. Community acquired pneumonia is an important cause of morbidity and mortality in children, with an annual global incidence in developed countries of 14.5 cases per 100,000 inhabitants between 0 and 16 years old. Materials and methods. Cross-sectional observational study, between September 2013 and August 2014. Results. The sample size was 107 patients, 51% of whom required hospitalization, 25% of them with atypical pneumonia caused by Mycoplasma pneumoniae. In the clinical analysis, 86% presented with fever, 9% of cases were associated with abdominal pain, and in 1% of the cases abdominal pain was the only manifestation. 50% of the radiographs showed an alveolar pattern. An etiologic diagnosis was obtained in 27% of the patients. 34% of the patients received empirical antibiotic therapy for atypical pneumonia and 45% of the patients were treated for typical pneumonia. In this last group, it was necessary to add macrolides afterwards in 46% of the cases due to a lack of clinical improvement. 50% of the serologies performed were Mycoplasma IgM-positive (19% of the total sample). In that group, 43% of them were initially treated as typical pneumonia, and in 77% of the cases it was necessary to add macrolides due to the persistence of the clinical symptoms. Conclusions: &#150; A higher incidence of hospitalized patients with pneumonia caused by Mycoplasma was observed, compared with the 2 previous years. &#150; Atypical pneumonia may present with the criteria of typical pneumonia. In these patients, an empirical treatment should be considered for both etiologies. &#150; If a patient with suspicion of typical pneumonia and an adequate empirical treatment shows a poor evolution, an infection must be suspected, or antibiotics for Mycoplasma must be added in the context of an epidemic outbreak   (AU)</dc:description>
<dc:creator>Sánchez-Villares Lorenzo, C</dc:creator>
<dc:creator>Sánchez Granados, JM</dc:creator>
<dc:creator>Férnandez Luis, S</dc:creator>
<dc:creator>Serrano Ayestarán, O</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción. La neumonía adquirida en la comunidad es una causa importante de morbi-mortalidad en niños, con una incidencia global anual en países desarrollados de 14.5 por 100.000 habitantes entre 0 y 16 años. Material y método. Estudio transversal y observacional, entre septiembre de 2013 y agosto 2014. Resultados. Muestra de 107 pacientes, el 51% precisaron ingreso, 25% de ellos por neumonía atípica por Mycoplasma pneumoniae. En la clínica el 86% presentaban fiebre, 9% casos se asociaban a dolor abdominal y en 1% el dolor abdominal era la única manifestación. El 50% de las radiografías presentaban patrón alveolar. Se obtuvo el diagnóstico etiológico en el 27% pacientes. El 34% recibió antibioterapia empírica para neumonía atípica y 45% para neumonía típica. De los últimos, el 46% precisaron añadir posteriormente macrólidos por no mejoría clínica. El 50% de las serologías solicitadas eran IgM positivas para Mycoplasma (19% de la muestra total). De ellas, el 43% fueron tratadas inicialmente como neumonía típica y el 77% preció añadir macrólidos por persistencia de la clínica. Conclusiones: &#150; Se observó mayor incidencia de neumonías por Mycoplasma ingresadas con respecto a los 2 años previos. &#150; La neumonía atípica se puede presentar con criterios de neumonía típica. En estos pacientes, habría que valorar iniciar tratamiento empírico frente a ambas etiologías. &#150; Ante la mala evolución de un paciente con sospecha de neumonía típica con tratamiento empírico adecuado, se debe sospechar complicación o añadir antibiótico frente a Mycoplasma en el contexto de brote epidémico (AU)</dc:description>
<dc:source>Bol. pediatr;55(231): 25-31, 2015. ilus</dc:source>
<dc:identifier>ibc-134992</dc:identifier>
<dc:title xml:lang="es">Neumonías adquiridas en la comunidad en el Hospital Universitario de Salamanca</dc:title>
<dc:subject>^d7399</dc:subject>
<dc:subject>^d29315</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d9369^s22052</dc:subject>
<dc:subject>^d28589^s22083</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d2715</dc:subject>
<dc:subject>^d11443^s22080</dc:subject>
<dc:subject>^d11448^s22080</dc:subject>
<dc:subject>^d31549^s22080</dc:subject>
<dc:subject>^d911^s22073</dc:subject>
<dc:type>article</dc:type>
<dc:date>201500</dc:date>
</metadata>
</record>
</ibecs-document>
